Hustenelixir - Drops 3 D Drops ; Liquid is a Health Canada–registered human drug (DIN 02173824) held by Weleda AG Heilmittelbetriebe, containing Drosera Rotundifolia. Health Canada lists its status as Cancelled Post Market (status date 27 Aug 2004). Nexara Health has matched 23 registrations of Drosera Rotundifolia across 3 other regulated markets.
Health Canada registration
| DIN | 02173824 |
|---|---|
| Brand name | Hustenelixir - Drops |
| Active ingredient | Drosera Rotundifolia |
| Strength | 3 D |
| Dosage form | Drops ; Liquid |
| Route | Oral |
| Company | Weleda AG Heilmittelbetriebe |
| Status | Cancelled Post Market — 27 Aug 2004 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Drosera Rotundifolia registered in other markets
23 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Drosera rotundifolia | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Drosera rotundifolia | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| United Arab Emirates | Drosera - Boiron | BOIRON, France, Messimy | 1 DH - 200 CH | Pillules | Active | EDE |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC | |
| United States | Drosera | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Drosera Rotundifolia worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hustenelixir - Drops (DIN 02173824) marketed in Canada?
No. Health Canada lists DIN 02173824 as Cancelled Post Market as of 27 Aug 2004.
Who holds the Canadian licence for this product?
Weleda AG Heilmittelbetriebe is the company of record in the Health Canada Drug Product Database.
Is Drosera Rotundifolia registered outside Canada?
Yes — Nexara Health has matched 23 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02173824, status date 2004-08-27; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02173824, status date 2004-08-27; national medicine registries: EDE, EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02173824, status date 2004-08-27; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.